ArticleJournal for immunotherapy of cancer2019

Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations.

Vidyalakshmi Chandramohan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.